ESC Premium Access

LDL cholesterol, apolipoprotein B, lipoprotein(a), apolipoprotein CIII and triglyceride lowering by MGL-3196, a thyroid hormone beta selective agonist, in a 12 week study in HeFH patients

Presentation

About the speaker

Doctor Rebecca Taub

Madrigal Pharmaceuticals, Conshohocken (United States of America)
0 follower

20 more presentations in this session

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Speaker: Doctor I. Dykun (Essen, DE)

Thumbnail

Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

Speaker: Doctor D. Huber (Umea, SE)

Thumbnail

Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients

Speaker: Doctor Y. Kumada (Kasamatsu, JP)

Thumbnail

The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris

Speaker: Doctor G. Svingen (Bergen, NO)

Thumbnail

Post-prandial remnant lipoprotein metabolism in sitosterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Thumbnail

Access the full session

Poster Session 6 - Preventive cardiology / Lipids

Speakers: Doctor R. Taub, Doctor I. Dykun, Doctor D. Huber, Doctor Y. Kumada, Doctor G. Svingen...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk